+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Resistant Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Resistant Hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Renal Anemia- Pipeline Insight, 2025 - Product Thumbnail Image

Renal Anemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Oral Mucositis - Pipeline Insight, 2025 - Product Thumbnail Image

Oral Mucositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Optic Neuritis- Pipeline Insight, 2025 - Product Thumbnail Image

Optic Neuritis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lupus Nephritis - Pipeline Insight, 2025 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Insulin Resistance - Pipeline Insight, 2025 - Product Thumbnail Image

Insulin Resistance - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hepatitis D - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis D - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Hepatitis A - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis A - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Hepatic Encephalopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatic Encephalopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hemostasis - Pipeline Insight, 2025 - Product Thumbnail Image

Hemostasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glomerulonephritis - Pipeline Insight, 2025 - Product Thumbnail Image

Glomerulonephritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dystonia - Pipeline Insight, 2025 - Product Thumbnail Image

Dystonia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Chronic Bronchitis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Bronchitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Von Willebrand's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Von Willebrand's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Viral Conjunctivitis - Pipeline Insight, 2025 - Product Thumbnail Image

Viral Conjunctivitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Seizures - Pipeline Insight, 2025 - Product Thumbnail Image

Seizures - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more